Pulmozyme Related Published Studies
Well-designed clinical trials related to Pulmozyme (Dornase Alfa)
Inhaled Dornase alfa (Pulmozyme) as a noninvasive treatment of atelectasis in
mechanically ventilated patients. [2013]
Dornase alfa reduces air trapping in children with mild cystic fibrosis lung
disease: a quantitative analysis. [2005]
A two-year randomized, placebo-controlled trial of dornase alfa in young patients
with cystic fibrosis with mild lung function abnormalities. [2001]
Effects of 12-week administration of dornase alfa in patients with advanced
cystic fibrosis lung disease. Pulmozyme Study Group. [1996]
Effect of aerosolized recombinant human DNase on exacerbations of respiratory
symptoms and on pulmonary function in patients with cystic fibrosis. The
Pulmozyme Study Group. [1994]
Well-designed clinical trials possibly related to Pulmozyme (Dornase Alfa)
Effect of recombinant human deoxyribonuclease on oropharyngeal secretions in
patients with head-and-neck cancers treated with radiochemotherapy. [2013]
The use of rhDNAse in severely ill, non-intubated adult asthmatics refractory to
bronchodilators: a pilot study. [2012]
Composite spirometric-computed tomography outcome measure in early cystic
fibrosis lung disease. [2003]
[Socioeconomic evaluation of the effect of rhDNase on the cost of treating
infections of the respiratory tract in patients with cystic fibrosis]. [Article in German] [1995]
Other research related to Pulmozyme (Dornase Alfa)
Timing of dornase alfa inhalation for cystic fibrosis. [2013]
Timing of dornase alfa inhalation for cystic fibrosis. [2011]
Dornase alfa for cystic fibrosis. [2010]
Does the timing of inhaled dornase alfa matter? [2009]
Is a longer time interval between recombinant human deoxyribonuclease (dornase
alfa) and chest physiotherapy better? A multi-center, randomized crossover trial. [2007]
Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. [2005]
A crossover, randomized, controlled trial of dornase alfa before versus after
physiotherapy in cystic fibrosis. [2005]
Dornase alfa in early cystic fibrosis lung disease. [2002]
Effect of smaller droplet size of dornase alfa on lung function in mild cystic
fibrosis. Dornase Alfa Nebulizer Group. [1998]
Comparison of three jet nebulizer aerosol delivery systems used to administer
recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase
Study Group. [1995]
Dornase alfa. A review of its pharmacological properties and therapeutic
potential in cystic fibrosis. [1994]
Other possibly related research studies
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. [2009]
DNase in stable cystic fibrosis infants: a pilot study. [2003]
rhDNase therapy for the treatment of cystic fibrosis patients with mild to
moderate lung disease. [1999]
Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. [1995]
Medical management of chronic rhinosinusitis in cystic fibrosis: a systematic
review. [2014]
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. [2013]
Nebuliser systems for drug delivery in cystic fibrosis. [2013]
|
